Lilly to buy Armo Biosciences for $1.6 billion to bolster cancer pipeline

(Reuters) - Eli Lilly and Co said on Thursday it would buy Armo BioSciences Inc for about $1.6 billion to expand its portfolio of drugs that helps body's immune system fight cancer as the U.S. drugmaker chases rivals in a lucrative market.

from Reuters: Health News https://ift.tt/2G170pq